Femasys (FEMY) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

FEMY Femasys

Watchlist

1.1400
+0.0100+0.88%

Close Jul 26 16:00 ET

1.1300
-0.0100-0.88%

Post 20:02 ET

25.33MMarket Cap-1341P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
BenzingaJun 20 13:26 ET
12 Health Care Stocks Moving In Thursday's Intraday Session
BenzingaJun 20 12:32 ET
Deep Dive Into Femasys Stock: Analyst Perspectives (4 Ratings)
BenzingaJun 20 12:00 ET
Femasys Secures CE Mark Approvals for Four Women's Health Products; Shares Up Over 14%
MT NewswiresJun 20 09:45 ET
Express News | Femasys Shares Are Trading Higher After Receiving CE Mark Approval From the EU MDR for Its FemaSeed, FemVue, FemCerv, and FemCath Products
BenzingaJun 20 08:37 ET
Express News | Femasys Receives CE Mark Approval From The EU MDR For Its FemaSeed, FemVue, FemCerv And FemCath Products
BenzingaJun 20 08:34 ET

Comments

Kaylin Dad2010

Jun 20 14:15

$Femasys(FEMY.US)$ 8k report: On June 20, 2024, Femasys Inc., a biomedical company specializing in women's health, announced the receipt of CE Mark approval for four of its products, enabling the start of commercialization efforts in Europe. The approved products, which include FemaSeed, FemVue, FemCerv, and FemCath, comply with the European Union Medical Device Regulation (EU MDR). This regulatory milestone follows the company's recent completion of its commercial team in the United States and ...